Physician

Adel M Zakari, M.D.

According to 2025 Medicare claims, Adel Zakari, M.D. (NPI: 1114053287) practices anesthesiology in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is ADVANCED PAIN MANAGEMENT INSTITUTE, LLC (NPI: 1760812952; TIN: 46-3980173) and primary practice location at 44718-2771. Zakari is affiliated with the IHC Quality Partners, LLC (ACO ID: A2833), participating under the MSSP model.

Zakari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 155 traditional Medicare patients, billed 2,010 HCPCS/CPT codes, and received $107,660 in Medicare payments. The top billing code was 62323 (Injection of substance into lower spine canal using imaging guidance). Part D data shows 1,777 prescription claims across 365 beneficiaries totaling $49,425 in drug costs, led by Nucynta (Tapentadol Hcl). 2019 DME data shows 12 claims. Open Payments data shows 16 records totaling $268. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $66,482 to $49,425. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,751 to $372.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	259	3,499	$134,125
2016	271	3,897	$149,755
2017	281	4,110	$168,431
2018	250	3,714	$153,654
2019	232	3,776	$165,983
2020	170	1,828	$83,023
2021	143	3,364	$129,627
2022	149	2,454	$112,944
2023	146	2,385	$126,040
2024	155	2,010	$107,660

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	323	1,676	$66,482
2016	352	1,819	$86,744
2017	336	1,774	$86,449
2018	372	1,896	$83,337
2019	366	1,958	$78,884
2020	287	1,534	$37,982
2021	225	1,167	$29,801
2022	226	1,171	$26,878
2023	247	1,181	$35,726
2024	365	1,777	$49,425

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	57	$2,800
2016	N/R	75	$1,808
2017	N/R	34	$530
2018	N/R	15	$234
2019	N/R	12	$168
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
62323	Injection of substance into lower spine canal using imaging guidance	41	51	$184
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	54	54	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	81	290	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	89	220	$65
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	97	922	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nucynta	Tapentadol Hcl	12	261	$10,971
Buprenorphine	Buprenorphine	24	672	$9,429
Pregabalin	Pregabalin	206	9,968	$7,643
Gabapentin	Gabapentin	238	15,703	$3,266
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	196	4,800	$1,903

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$268	Forte Bio-Pharma LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adel M. Zakari, M.D.?

Tedicare shows public-source Medicare data for Adel M. Zakari, M.D. (NPI 1114053287), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adel M. Zakari, M.D. have ACO affiliation data?

Adel M. Zakari, M.D. is shown with ACO affiliation data for IHC Quality Partners, LLC (MSSP, ACO ID A2833).

What billing organization is linked to Adel M. Zakari, M.D.?

Adel M. Zakari, M.D. is linked to ADVANCED PAIN MANAGEMENT INSTITUTE, LLC (billing NPI 1760812952) in the available physician profile data.

Does Adel M. Zakari, M.D. have Open Payments data?

Adel M. Zakari, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.